Infectious diseases know no boundaries. An outbreak anywhere is a threat everywhere.
In a move that severs decades of institutional partnership, the Centers for Disease Control and Prevention has been ordered to cut all communication with the World Health Organization, implementing President Trump's executive order to formally withdraw the United States from the agency. The directive arrives at a moment of particular consequence — just weeks before a critical WHO committee convenes to select influenza strains for the next season's vaccines, a process in which American scientific expertise has long played a central role. What unfolds now is not merely a bureaucratic realignment, but a renegotiation of how the world's most powerful nation chooses to participate in the shared project of protecting human life across borders.
- A single email from a CDC deputy director has effectively unplugged the United States from the global health communication network it helped build over generations.
- The blackout lands at the worst possible moment — a WHO flu strain selection meeting next month could proceed without American scientists whose Atlanta lab is one of the world's foremost centers for detecting pandemic-level mutations.
- Former officials warn that the withdrawal doesn't just weaken the WHO — it blinds the U.S. itself, since American health agencies often learned of dangerous outbreaks first through WHO channels, especially from nations reluctant to share data directly.
- China, already seeking to expand its footprint within the UN health agency, stands ready to fill positions vacated by departing American experts, potentially reshaping whose values and priorities guide global disease response.
- The full scope of exceptions to the communications ban remains undefined, leaving CDC staff in limbo and critical collaborations — from polio eradication to Marburg outbreak response — suddenly suspended mid-mission.
On Monday, CDC staff received an order that few could have imagined arriving so abruptly: cease all communication with the World Health Organization. The directive, issued by CDC Deputy Director John Nkengasong, also instructed American personnel assigned to WHO positions to stay away from the office pending further guidance. It was the operational expression of President Trump's executive order calling for a formal one-year U.S. withdrawal from the agency — a process that strips WHO of its largest single donor and pulls American experts from positions they have held for decades.
Trump has long accused the WHO of mishandling COVID-19 and of allowing the United States to shoulder a disproportionate financial burden. At a Las Vegas appearance days before the directive, he left open the possibility of returning if the organization reformed itself, but the machinery of withdrawal was already in motion.
The timing carries immediate consequences. Next month, a WHO committee is scheduled to select the influenza strains that will shape the coming winter's vaccines across the Northern Hemisphere. CDC scientists were expected to participate — their Atlanta laboratory is one of the world's premier facilities for analyzing flu mutations that might signal pandemic risk. Countries around the globe routinely send samples there for evaluation. Without American input, that process faces a significant gap.
Former officials sounded urgent alarms. James LeDuc, a veteran of both the CDC and WHO, warned that the withdrawal could cripple the disease surveillance systems that give the world — and the United States — early warning of emerging threats. He noted that infectious diseases respect no borders, and that the WHO's global mandate has no real substitute. American officials, he pointed out, often learned of dangerous outbreaks first through WHO networks, particularly from nations reluctant to engage Washington directly.
The practical losses extend further. CDC staff have served as liaisons to WHO disease experts, contributed to the Global Polio Eradication Initiative, and helped coordinate access to medicines and vaccine trials for smaller nations facing outbreaks. The WHO was instrumental in facilitating the U.S. vaccine response during last year's Marburg outbreak in Rwanda — and authorities are now monitoring a new Marburg outbreak in Tanzania.
Loyce Pace, who led global affairs for the Department of Health and Human Services under the Biden administration, noted that hundreds of American health officials work within the WHO structure. She expressed concern that China — already seeking to expand its influence inside the UN agency — would move quickly to claim the space left behind. The WHO declined to comment. What remains is the unsettling reality that a public health architecture assembled over generations is being dismantled in real time, with the consequences still taking shape.
On Monday, staff at the Centers for Disease Control and Prevention received an order that severed a relationship spanning decades: stop all communication with the World Health Organization. The directive came from John Nkengasong, the CDC's Deputy Director for Global Health, in an email instructing employees to cut ties with the U.N. health agency. The order also told CDC staff assigned to WHO positions not to report to the office, pending further guidance from leadership. The move implements President Trump's executive order from the previous week, which called for the U.S. to begin a formal one-year withdrawal from WHO funding and instructed federal agencies to "recall and reassign" any American personnel working with the organization.
Trump has long criticized the WHO, arguing the organization bungled its response to COVID-19 and that the United States contributes too much money while other nations contribute far less. At a Las Vegas event on January 25, he noted that the WHO had offered to reduce the U.S. funding commitment to roughly the level China provides. "Maybe we would consider doing it again," he said. "They have to clean it up a little bit." The U.S. is the largest single donor to the organization, and the withdrawal process will take a full year to complete.
The timing of the communications blackout creates immediate complications. Next month, a key WHO committee is scheduled to meet to select influenza strains for the coming winter's vaccine. CDC officials were expected to participate in this selection process, which shapes the shots that manufacturers and the FDA will produce for distribution across the Northern Hemisphere each fall. The CDC operates as one of the world's premier laboratories for studying influenza, and countries around the globe send samples of concerning flu cases to the agency's Atlanta facility to be analyzed for mutations that might signal pandemic risk. Without American input at that critical meeting, the vaccine development process faces disruption.
Former federal health officials expressed alarm about the broader consequences. James LeDuc, who worked as a CDC officer for the WHO and later held senior positions in the agency's global health division, warned that the U.S. withdrawal could cripple disease surveillance and pandemic preparedness. "Infectious diseases know no boundaries and in today's world of rapid travel, an outbreak anywhere is a threat everywhere," he said. The WHO, he emphasized, has a global mandate that allows health issues to be addressed on a coordinated international scale. "The fact is that there is no alternative to WHO." American officials often learned about worrying disease outbreaks first through the WHO, particularly in countries reluctant to share information directly with U.S. authorities. The organization also depends on disease experts dispatched by the United States and other nations to staff its operations.
The practical work that American health officials perform through the WHO extends across multiple fronts. CDC staff serve as liaisons with the agency's disease experts, offering insights into emerging pathogens the organization is tracking globally. Americans work with other countries on initiatives like the Global Polio Eradication Initiative, a joint effort between the CDC and WHO to eliminate the disease. The organization also plays a crucial role in licensing medicines and coordinating trials that allow countries—especially smaller nations facing new disease outbreaks—to access treatments. Former federal officials noted that the WHO was instrumental in facilitating the response and rollout of a U.S. vaccine during last year's Marburg outbreak in Rwanda, an Ebola-like disease. This year, authorities are closely monitoring another Marburg outbreak in Tanzania, which the WHO confirmed last week.
Loyce Pace, who directed global affairs for the Department of Health and Human Services under the Biden administration, said hundreds of American health agency officials work with the WHO. She expressed concern that other countries will move to fill the void left by departing American experts. China, in particular, has been seeking to expand its presence within the U.N. agency, a development that worries some U.S. officials about how those positions might be leveraged. "My hope is that there's a part of us that will continue to work to see that not as a weakness but as a strength," Pace said, noting that the American approach of working as both national representatives and global citizens has historically been more effective at building partnerships to protect public health worldwide.
The World Health Organization declined to comment on the directive. The Department of Health and Human Services, which oversees the CDC, did not immediately respond to requests for comment. The full scope of exceptions to the communications ban remains unclear, pending further guidance from CDC leadership. What is clear is that American public health infrastructure, built over decades through WHO collaboration, is now being dismantled in real time, with consequences that will unfold across disease surveillance, vaccine development, and the nation's ability to respond to the next emerging threat.
Citas Notables
There is no alternative to WHO. WHO has the global mandate that allows health issues to be addressed on a global scale in a coordinated manner.— James LeDuc, former CDC WHO officer and global health official
My hope is that there's a part of us that will continue to work to see that not as a weakness but as a strength, to distinguish us from other actors who don't have that approach.— Loyce Pace, former HHS director of global affairs
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that the CDC can't talk to the WHO? Isn't the CDC capable of handling disease on its own?
The CDC is excellent at what it does domestically, but diseases don't stop at borders. The WHO is how American officials learn about outbreaks in countries that won't talk directly to the U.S., and it's how the world coordinates responses. Without that channel, America becomes reactive instead of proactive.
What's the immediate practical problem here?
There's a flu vaccine meeting next month. The CDC was supposed to help select which strains go into next winter's vaccine. Without American input, that process gets weaker, and the shots people get in the fall might be less effective.
Can other countries just replace American expertise?
They can try. China is already moving to fill those positions. But the concern isn't just about losing seats at the table—it's about losing the relationships and trust that took decades to build. American health officials worked alongside scientists from former adversaries. That kind of collaboration doesn't get rebuilt quickly.
Is this reversible?
The formal withdrawal takes a year, so technically yes. But the relationships and institutional knowledge being lost right now—that's harder to restore. People move on. Partnerships fracture. The damage compounds.
What happens if there's a disease outbreak tomorrow?
The U.S. would be flying blind in parts of the world. The WHO would be the first to know, but the CDC wouldn't be in the room. America would be responding to news instead of helping shape the response.